In this review the dielectric properties of relaxor ferroelectrics are discussed and compared with the properties of normal dielectrics and ferroelectrics. We try to draw a general picture of dielectric relaxation starting from a textbook review of the underlying concepts and pay attention to common behavior of relaxors rather than to the features observed in specific materials. We hope that this general approach is beneficial to those physicists, chemists, material scientists and device engineers who deal with relaxors. Based on the analysis of dielectric properties, a comprehensive definition of relaxors is proposed: relaxors are defined as ferroelectrics in which the maximum in the temperature dependence of static susceptibility occurs within the temperature range of dielectric relaxation, but does not coincide with the temperature of singularity of relaxation time or soft mode frequency.
The microstructure and phase transition in relaxor ferroelectric Pb(Mg 1/3 Nb 2/3 )O 3 (PMN) and its solid solution with PbTiO 3 (PT), PMN-xPT, remain to be one of the most puzzling issues of solid state science. In the present work we have investigated the evolution of the phase symmetry in PMN-xPT ceramics as a function of temperature (20 K < T < 500 K) and composition (0 ≤ x ≤ 0.15) by means of high-resolution synchrotron x-ray diffraction. Structural analysis based on the experimental data reveals that the substitution of Ti 4+ for the complex B-site (Mg 1/3 Nb 2/3 ) 4+ ions results in the development of a clean rhombohedral phase at a PT-concentration as low as 5%. The results provide some new insight into the development of the ferroelectric order in PMN-PT, which has been discussed in light of the kinetics of polar nanoregions and the physical models of the relaxor ferroelectrics to illustrate the structural evolution from a relaxor to a ferroelectric state.
The (1−x)BaTiO3–xBaSnO3 (0⩽x⩽0.30) perovskite solid solution ceramics were prepared by solid state reaction and studied by dielectric spectroscopy. The complex dielectric permittivity was measured as a function of frequency (0.1Hz–100kHz) in the temperature (T) range of 123–573K. The transition from the high-temperature paraelectric state where the dielectric constant obeys the Curie-Weiss law to the ergodic cluster state is found to occur at the same temperature of 485K in all the compositions of x⩾0.04 and at lower temperatures in those with a smaller x. For 0⩽x⩽xc=0.19, the temperature of the dielectric peak Tm, corresponding to the diffuse transition from the ergodic polar cluster state to the ferroelectric state, decreases with increasing x and does not depend on frequency. The diffuseness of the peak gradually increases. For x>xc, the permittivity exhibits relaxor behavior with the frequency-dependent Tm satisfying the Vogel-Fulcher law. The temperature variation of the permittivity on the high-temperature slope of the peak (T>Tm) is characterized by the characteristic Lorenz-type quadratic law for relaxors, with the diffuseness increasing with the increase of x. The mechanisms of the dielectric response in different parts of the phase diagram are discussed. In particular, the crossover from diffuse ferroelectric phase transition to relaxor ferroelectric behavior is attributed to the appearance at x>xc of the additional dielectric contribution arising from the flipping of the local polarization of the polar clusters. The temperature-composition phase diagram of the Ba(Ti1−xSnx)O3 system has been established, which delimits the paraelectric, ergodic polar cluster, nonergodic ferroelectric, and relaxor phases (states) and indicates the crossover from ferroelectric to relaxor behavior at x=xc.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.